The largest database of trusted experimental protocols

207 protocols using chlorpromazine

1

Endocytic Pathway Modulation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
When treating cells with chlorpromazine or Filipin, cells were first incubated with 10 µg/ml chlorpromazine (Sigma) or 5 µg/ml Filipin (Sigma) in 10% FBS McCoy’s 5 A medium for 30 min. After that, the cells were incubated with 4 μM PV-1 and 5 μM Tubulin-FITC for 1 h. Then cells were washed with PBS and incubated in 10% FBS fresh medium for 1 h.
When treating with EIPA (5-(N-ethyl-N-isopropyl) amiloride), cells were incubated with 100 μM EIPA, 4 μM PV-1, and 5 μM Tubulin-FITC for 1 h. After that, the cells were washed with PBS and incubated in cell culture medium 10% FBS for 1 h.
After the above treatment, cells were imaged by confocal microscopy or analyzed by microcapillary flow cytometer (Guava easyCyte 8HT, EMD Millipore Corporation).
+ Open protocol
+ Expand
2

Inhibition of Cellular Processes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following small molecules were used for the chemical inhibition of specific proteins or cellular processes: brefeldin A (B6542, Sigma-Aldrich), chlorpromazine (C8138, Sigma-Aldrich), cytochalasin D (C8273, Sigma-Aldrich), dynasore hydrate (D7693, Sigma-Aldrich), dynole 34–2 (ab120463, Abcam), dynole 31–2 (ab120464, Abcam), Exo1 (#1850, Tocris), latrunculin A (L5163, Sigma-Aldrich), monodansylcadaverine (30432, Sigma-Aldrich). Except for brefeldin A and chlorpromazine, which were diluted in ethanol or water respectively, all stock solutions were prepared using dimethyl sulfoxide (DMSO, #276855, Sigma-Aldrich). Cells were preincubated at 37°C and 5% CO2 with the specific inhibitors diluted in HBSS for 60min (cytochalasin D, latrunculin A) to 100min (all others) and were present during all functional analyses.
+ Open protocol
+ Expand
3

Inhibiting Aβ Transport Mechanisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Various inhibitors were used to study the transport mechanisms of Aβ and its isoforms. The contribution of RAGE to the transport of Aβ across the endothelial monolayer was assessed using the antagonist of this receptor FPS-ZM1 (Sigma) at a concentration of 20 μM (to obtain a stock solution, FPS-ZM1 was dissolved in DMSO to a concentration of 305 mM). To study the caveolin-dependent transport of Aβ isoforms, the inhibitor filipin (Sigma) was used at a concentration of 3 μg/ml (to obtain a stock solution, filipin was dissolved in DMSO to a concentration of 5 mg/ml). An equivalent amount of DMSO was added to the control samples. The contribution of clathrin-dependent endocytosis was assessed using chlorpromazine (Merck) at a concentration of 5 μg/ml (to obtain a stock solution, chlorpromazine was dissolved in DMEM). These concentrations were selected based on literature data and tested for toxicity to bEnd.3 cells using MTT (filipin) and WST (FPS-ZM1 and chlorpromazine) assays according to the manufacturer's protocol (Supplementary Figure 2). Before experiments, cells were preincubated with inhibitors added to the upper transwell compartment for 1 h, after which they were filled with solutions containing the inhibitor and 1 μM Aβ, and samples were taken from the lower compartment after 2, 6 and 24 h.
+ Open protocol
+ Expand
4

Endocytosis Inhibition Impact on AuNPs Uptake

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 6-well culture plates at a density of 500000 cells/well, after 24 h incubated with different endocytosis inhibitors [2.5 mM amiloride (Sigma-Aldrich), 2.5 μg/mL chlorpromazine (Sigma-Aldrich) and 100 μM indomethacin (Sigma-Aldrich)] and then maintained for 1 h at 37°C with 5% of CO2-air. The concentrations and treatment times of each chemical inhibitors were optimized in a preliminary experiment to select the maximum non-toxic doses and treatment times. After 1 h incubation, the inhibitors were removed, and the cells exposed to 2 μg/mL AuNPs in complete medium for 24 h incubation. Then ICP-MS protocol was followed as described in the previous section.
+ Open protocol
+ Expand
5

STBEV Internalization in Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vitro STBEV-exposure experiments, prepared vessel segments were immersed in carbonated Na-Krebs buffer (pH 7.3–7.4) in Eppendorf tubes, while gently shaking. Vessels were incubated for 2 h at 37 °C with buffer, or buffer containing 40 µg/ml PE or normal STBEVs with and without 10 µg/ml chlorpromazine (Sigma-Aldrich) or 10 µg/ml anti-LOX-1 antibody (TS92, provided by Professor Tatsuya Sawamura, Japan). The vessels were thereafter fixed for further microscopy analysis. The experiment was run twice. As stated above, we have previously shown that placenta-derived STBEVs are internalized by human endothelial cells within 30 min of incubation32 (link).
+ Open protocol
+ Expand
6

Investigating Endocytic Pathways in HL-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endocytosis mechanisms were inhibited by treating the cells with pharmacological inhibitors and incubating them at 4 °C. HL-1 cells were pretreated using different inhibitors, such as 10 μM of chlorpromazine (Sigma) to inhibit clathrin-mediated endocytosis, 20 μM of genistein (Sigma) to inhibit caveolae-mediated endocytosis, 10 µM of EIPA (Cayman Chemical) and 4 µM of cytochalasin D (Sigma) to inhibit macropinocytosis. The cells were incubated for 30 min at 37 °C before the exposure to HAp/pDNA complexes. Energy-dependent endocytic processes were reduced by preincubating the cells at 4 °C for 30 min prior to HAp/pDNA complex exposure. After preincubation, the complexes (final concentration of 100 ng/mL) were added and incubated for 4 h, either in the presence of the inhibitors or at 4 °C. Then, the cells were washed three times using PBS to remove the remaining HAp nanoparticles and fresh medium was added. The cells were incubated for an additional 24 h before assessment. The relative transfection rate was normalized to that observed in the absence of inhibitors (100%).
+ Open protocol
+ Expand
7

Pharmacological Compound Preparation for Cell Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock solution of 4-hydroxytamoxifen (4-HT) (Sigma) was dissolved in ethanol and stored at -20°C. Stock solutions of chloroquine diphosphate (CQ), desipramine (DSP), chlorpromazine (CPZ) and promethazine (PMZ) (all from Sigma), were prepared fresh before each experiment, by dissolving in phosphate buffered saline (PBS) and filter sterilization. Stock solutions of L-leucyl-L-leucyl methyl ester (Sigma) was prepared freshly before each experiment, by dissolving in DMSO. Stock solution of Z-Phe-Ala fluoromethyl ketone (Z-Phe-Ala; Sigma) was prepared in DMSO. Vehicle controls consisted of equivalent amounts, all < 1%, of DMSO (LeuLeu-OMe), PBS (CQ, CPZ, PMZ) and ethanol (4-HT). Monensin (Sigma) was prepared at a final concentration of 100 nM in ethanol. The concentration of Monensin was optimized to be the lowest concentration that inhibited lysotracker accumulation in lysosomes, yet did not obviously affect cell growth after 6 hours (data not shown).
+ Open protocol
+ Expand
8

Endocytosis inhibitors modulate BMP-2 uptake

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endocytosis inhibitors (chlorpromazine, genistein, and dynasore; all from Sigma‐Aldrich) were prepared as stock solutions in distilled water or dimethyl sulfoxide (DMSO), as described previously8 (link). Exponentially growing DG44 cells were incubated at 37 °C for 30 min in IMDM plus 1 × HT containing 10 µM chlorpromazine, 200 µM genistein, or 100 µM dynasore. As a control, cells in IMDM plus 1 × HT without an endocytosis inhibitor and cells in IMDM plus 1 × HT with 20 µL DMSO were also incubated under the same conditions. The cells were then incubated at 37 °C for 3 h in IMDM plus 1 × HT with 10 µg/mL of rhBMP-2. Following this, cells were washed with ice-cold acidic buffer and PBS to remove the surface-bound rhBMP‐2 and harvested by trypsinization for further analyses.
+ Open protocol
+ Expand
9

Endocytosis Pathways of Nanodrug Formulations

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cells were seeded in a six-well plate at a density of 4 × 105 cells/well and incubated overnight. The cells were pre-incubated with inhibitors (i.e., 5-(N-Ethyl-N-isopropyl) amiloride (EIPA), chlorpromazine (CPZ) and genistein (GEN), Sigma) for 30 min at 37 °C to examine macropinocytosis and the uptake of caveolin and clathrin. Before treatment with each endocytosis inhibitor, cell viability was checked using MTT assay to ensure that any cytotoxic effect was due to treatment with endocytosis inhibitors. The nanodrugs investigated (i.e., DOX, encapsulation-DOX, covalent conjugation-DOX and PEG coat-DOX) were then incubated with cells for another 2 hrs. The DOX concentration of all nanodrugs was 200 ng/ml. The concentrations of EIPA, chlorpromazine and genistein were 25 μM, 20 μM and 200 μM, respectively. Cells were then washed twice with PBS and suspended in 500 ml of PBS supplemented with 1% FBS. The DOX fluorescence obtained from single cell suspensions were evaluated using a BD LSR II flow cytometer (Becton Dickinson Immunocytometry Systems) and analyzed using FlowJo software (Ver. 10.1, FlowJo, LLC). Single cell suspensions treated with nanodrugs without inhibitors served as controls.
+ Open protocol
+ Expand
10

Cellular Imaging Reagents Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
5-(N-Ethyl-N-isopropyl) amiloride (EIPA), blebbistatin, casin, chlorpromazine, cytochalasin D, dynasore, filipin complex, gefitinib (Iressa), genistein, IPA-3, nocodazole, NSC23766, rottlerin, salirasib, wortmannin, Y11, FluoromountTM, polyethylene glycol 8000 and Sepharose® 6B were from Sigma-Aldrich (St. Louis, MO, USA). Alexa Fluor® 633-conjugated transferrin, Lysine fixable Dextran-Texas Red®, 70,000 MW, Alexa Fluor® 594-conjugated cholera toxin subunit B and rhodamine phalloidin were from Molecular Probes, Thermo Fisher Scientific (Waltham, MA USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!